Viatris UK has announced that, from 1 March 2025, all orders of licensed Creon® preparations should be placed directly with Alliance Healthcare UK. This is a shift away from the current three-wholesaler (AAH, Alliance Healthcare UK and Phoenix) distribution model to using only Alliance Healthcare UK as the sole distributor of licensed Creon® preparations in
Read moreDrug alert number: EL(25)A/09 Date issued: 4 March 2025 Sun Pharmaceutical Industries Europe B.V. is recalling those product batches listed in this notification as a precautionary measure due to out of specification results reported for the Particulate Matter Test (PMT) during stability testing. Medicine Details Pemetrexed SUN 10 mg/ml solution for infusion (Infusion bag) (PL:
Read moreMHRA Class 3 Medicines Recall: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection Drug Alert Number: EL(25)A/08 Date issued: 03 March 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Azacitidine 100 mg/vial and 150 mg/vial Powder for Suspension for Injection DMRC reference
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Desmopressin 10microgram/dose nasal spray MSN/2025/010 Tier 2 medium impact Date of issue: 3rd March 2025 Desmopressin 10microgram/dose nasal spray is out of stock with an anticipated re-supply date of early September 2025. Unlicensed supplies of desmopressin 10microgram/dose nasal spray are available,
Read moreA high percentage of disallowed items are appliances or chemical reagents not listed in Part IX (the Appliances section) of the Drug Tariff or products ordered by dentists or community nurse prescribers which are not listed in their respective formularies. Recently, Community Pharmacy England has received queries from pharmacy owners concerned about the losses incurred
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (28/02/2025) announced the following list of price concessions for February 2025: This is not the final update for February. We are still working with the DHSC to agree
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free MSN/2025/014 Tier 2 – medium impact Date of issue: 06/03/2025 Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free is out of stock until late March 2025. Salbutamol pressurised metered-dose inhalers (pMDIs)
Read moreThe following price concessions granted in February 2025 have rolled over to March 2025: Drug Pack size March 2025 price concession Calamine lotion 200 £1.78 Colestyramine 4g oral powder sachets 50 £15.95 Nitrazepam 5mg tablets 28 £1.70 Rizatriptan 10mg orodispersible tablets sugar free 3 £8.18 Please note any rolled over prices can be adjusted upwards
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (05/03/2025) announced the following final list of price concessions for February 2025: Drug Pack size Price concession Desmopressin 240microgram sublingual tablets sugar free 30 £36.32 Paracetamol 500mg effervescent
Read more
Drug alert number: EL (25)A/10 Date issued: 4 March 2025 Aspar Pharmaceuticals Limited have informed the MHRA of an error related to a batch of Boots Paracetamol 500 mg tablets (16s). The foil blister inside the carton incorrectly states ‘Aspirin 300 mg Dispersible Tablets’. The tablets are confirmed to be Paracetamol 500 mg tablets. Boots
Read more
